NCT01475877已完成不适用
Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Post-PRK pain
研究概览
简要总结
This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •male or female at least 18 years of age,
- •no other ocular studies with 15 days prior to dosing,
- •BCVA 20/200 or better,
- •return for study visits and follow instructions from investigator and staff,
- •self administer test article
排除标准
- •Ocular inflammation,
- •hypersensitivity to bromfenac or nepafenac,
- •any corneal pathology,
- •have had radial keratotomy,
- •corneal transplant or corneal refractive surgery in the last two years
研究组 & 干预措施
Nepafenac
干预措施: Bromfenac (Drug)
结局指标
主要结局
Post-PRK pain
时间窗: 7 days
次要结局
- Post-PRK epithelial healing(7 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
on-steroidal anti-inflammatory drugs vs Steroids in the post operative management of inflammation following uncomplicated cataract surgeryEye DiseasesSurgerycataractPACTR201701001971511Dr Egagifo Ochuko100
已完成
不适用
Anti-inflamation effect of Bromfenac ophthalmic solution after selective laser trabeculoplasty.Primary Open Angle GlaucomaJPRN-UMIN000001172Kozawa Eye Hospital and Diabetes Center40
已完成
4 期
Bromfenac Versus Dexamethasone After Cataract SurgeryInflammation EyeNCT03317847Azienda USL Reggio Emilia - IRCCS92
Unknown
不适用
Observation on the Herpes Simplex KeratitisKeratitis, HerpeticNCT03013959Peking Union Medical College100
已完成
4 期
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract SurgeryMacular EdemaNCT01395069Queen's University162